Search results
Carolina Hurricanes work slowly into NHL free agency, pick up steam on the first day
Durham Herald-Sun· 22 hours agoThe Canes had hoped to re-sign Guentzel, a proven scorer and former Stanley Cup winner with the...
The World Cup That Cheers
rediff.com· 9 hours agoIMAGE: India players celebrate winning the T20 World Cup at Barbados. In the day-and-a-half since India won the International Cricket Council T20 World...
Volkswagen’s $5 billion bet on Rivian gets influencer attention on X
Just Auto· 1 day ago@VW to invest up to $5 billion in the EV startup, helping fund development of the R2 SUV, while VW...
Liquor firms in a twist over permit rollout in Punjab
Livemint· 11 hours agoA circular issued in Ludhiana district defined that retailers or retail groups can only buy 1,000...
10 Photos That Capture the Eternally Inspiring '70s Style of Linda Ronstadt
Woman's World· 19 hours agoHere's a look back at some of Linda Ronstadt's most fashionable moments as the singer whose voice...
Hindenburg Research responds to SEBI on Adani show cause notice: Five key points of defence | Mint
Livemint· 9 hours agoAdani-Hindenburg update: In a blog post dated July 1, Hindenburg Research responded to the...
Zydus Life shares gain on licensing agreement with Dr Reddy’s to market Pertuzumab Biosimilar
CNBC Awaaz· 1 day agoZydus Lifesciences share price was up marginally percent in the opening trade on July 1 after the...
SEBI Issues Show Cause Notice to Hindenburg Research | India Infoline
India Infoline· 6 hours agoHindenburg Research, a US-based activist short seller who accused Adani Group of stock manipulation and accounting fraud last year, has received a show cause notice from the Securities and Exchange ...
ESG Outlook: Thomasine Dolan of Material Innovation Initiative on Next-Gen Materials
Sourcing Journal· 24 hours agoThomasine Dolan, director of material innovation + design, Material Innovation Initiative, discusses...
Zydus, Dr Reddy's to co-market breast cancer treatment in India
CNBC Awaaz· 4 days agoPertuzumab is a critical treatment for HER2 positive breast cancer patients and the biosimilar has...